BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
20 results:

  • 1. Prognostic value of tertiary lymphoid structures (TLS) in digestive system cancers: a systematic review and meta-analysis.
    Sun H; Shi Y; Ran H; Peng J; Li Q; Zheng G; He Y; Liu S; Chang W; Xiao Y
    BMC Cancer; 2023 Dec; 23(1):1248. PubMed ID: 38110876
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable pancreatic Ductal Adenocarcinoma.
    Qian Y; Gong Y; Liu Y; Chen Y; Wang R; Dai Z; Zou X; Tasiheng Y; Luo G; Lin X; Wang X; Cheng H; Yu X; Liu C
    J Immunol Res; 2022; 2022():7353572. PubMed ID: 35910854
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rate of pancreatic cancer following a negative endoscopic ultrasound and associated factors.
    King D; Kamran U; Dosanjh A; Coupland B; Mytton J; Leeds JS; Nayar M; Patel P; Oppong KW; Trudgill NJ
    Endoscopy; 2022 Nov; 54(11):1053-1061. PubMed ID: 35359019
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [prognosis and Related Factors of Patients with Pathological Complete Response after Neoadjuvant Therapy for Gastric cancer].
    Wang TB; Zhou H; Zhang XJ; Sun CY; Guo CG; Chen YT; Zhou AP; Jin J; Zhao DB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Aug; 43(4):571-578. PubMed ID: 34494528
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Baseline HBV-DNA load plus AST/ALT ratio predicts prognosis of HBV-related hepatocellular carcinoma after hepatectomy: A multicentre study.
    Shen J; Dai J; Zhang Y; Xie F; Yu Y; Li C; Wen T
    J Viral Hepat; 2021 Nov; 28(11):1587-1596. PubMed ID: 34464991
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Single Hormone Receptor-Positive Metaplastic Breast cancer: Similar Outcome as Triple-Negative Subtype.
    Mao J; Hu J; Zhang Y; Shen J; Dong F; Zhang X; Ming J; Huang T; Run X
    Front Endocrinol (Lausanne); 2021; 12():628939. PubMed ID: 33972826
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]    [Full Text] [Related]  

  • 8. Mucinous cystic neoplasms of the pancreas in the modern era. Experience with 707 patients.
    Ahmad M; Maegawa FB; De La Rosa E; Davis B; Tyroch A; Konstantinidis IT
    Am J Surg; 2020 Dec; 220(6):1433-1437. PubMed ID: 32938530
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm.
    Mungo B; Croce C; Oba A; Ahrendt S; Gleisner A; Friedman C; Schulick RD; Del Chiaro M
    Ann Surg Oncol; 2021 Mar; 28(3):1533-1542. PubMed ID: 32743713
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Geriatric Nutritional Risk Index Predicts Adverse Outcomes in Human Malignancy: A Meta-Analysis.
    Lv GY; An L; Sun DW
    Dis Markers; 2019; 2019():4796598. PubMed ID: 31827634
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Prognostic value of important driver gene mutations in patients with radical resection of pancreatic cancer].
    Shen J; Gao SZ; Wang H; Shi XH; Li B; Pan YQ; Shen S; Shao Z; Guo SW; Jin G
    Zhonghua Wai Ke Za Zhi; 2019 Nov; 57(11):840-847. PubMed ID: 31694133
    [No Abstract]    [Full Text] [Related]  

  • 12. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
    Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
    Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The histopathologic type predicts survival of patients with ampullary carcinoma after resection: A meta-analysis.
    Zhou Y; Li D; Wu L; Si X
    Pancreatology; 2017; 17(2):273-278. PubMed ID: 28131524
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms.
    Kaltenborn A; Matzke S; Kleine M; Krech T; Ramackers W; Vondran FW; Klempnauer J; Bektas H; Schrem H
    J Surg Oncol; 2016 Feb; 113(2):194-202. PubMed ID: 26709239
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced pancreatic cancer Undergoing Chemotherapy.
    Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
    Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
    World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus.
    Oba A; Takahashi S; Kato Y; Gotohda N; Kinoshita T; Shibasaki H; Ikeda M; Konishi M
    Anticancer Res; 2014 Aug; 34(8):4367-72. PubMed ID: 25075073
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
    Templeton AJ; Ace O; McNamara MG; Al-Mubarak M; Vera-Badillo FE; Hermanns T; Seruga B; Ocaña A; Tannock IF; Amir E
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1204-12. PubMed ID: 24793958
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. RON is not a prognostic marker for resectable pancreatic cancer.
    Tactacan CM; Chang DK; Cowley MJ; Humphrey ES; Wu J; Gill AJ; Chou A; Nones K; Grimmond SM; Sutherland RL; Biankin AV; Daly RJ;
    BMC Cancer; 2012 Sep; 12():395. PubMed ID: 22958871
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.
    McMillan DC; Watson WS; O'Gorman P; Preston T; Scott HR; McArdle CS
    Nutr Cancer; 2001; 39(2):210-3. PubMed ID: 11759282
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.